Jonathan Schwartz

Jonathan Schwartz

Directeur Technique/Scientifique/R&D chez ROCKET PHARMACEUTICALS, INC.

Fortune : 1 M $ au 30/06/2026

62 ans
Health Technology
Consumer Services
Health Services

Profil

Jonathan David Schwartz currently works at Rocket Pharmaceuticals, Inc., as Chief Medical & Gene Therapy Officer from 2024.
Dr. Schwartz also formerly worked at Eli Lilly & Co., as Vice President-Clinical Science, Stemline Therapeutics, Inc., as Vice President-Clinical Development from 2014 to 2016, The Mount Sinai Medical Center, Inc., as Associate Professor, and Rocket Pharmaceuticals Ltd., as Chief Medical Officer & Head-Clinical Development.
Dr. Schwartz received his doctorate degree from Washington University in St. Louis and undergraduate degree from Brown University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
18/11/2025 299 064 ( 0,27 % ) 1 M $ 30/06/2026

Postes actifs de Jonathan Schwartz

SociétésPosteDébut
ROCKET PHARMACEUTICALS, INC. Directeur Technique/Scientifique/R&D 01/01/2016

Anciens postes connus de Jonathan Schwartz

SociétésPosteFin
STEMLINE THERAPEUTICS, INC. Corporate Officer/Principal 01/01/2016
Directeur Technique/Scientifique/R&D -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Jonathan Schwartz

Formation de Jonathan Schwartz

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

16

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Jonathan Schwartz
🔇